Therabron Therapeutics Receives FDA Fast Track Designation for rhCC10 for the Prevention of Chronic Lung Disease Related to Premature Birth

ROCKVILLE, MD, April 28, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, announced today that it has received Fast Track Designation […]

By |April 28th, 2016|Uncategorized|

Therabron Therapeutics to Present at World Orphan Drug Congress USA 2016

ROCKVILLE, MD, April 19, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that Dr. Thomas F. Miller, President […]

By |April 20th, 2016|Uncategorized|

Therabron Therapeutics Receives Notice of Allowance for New Patent Supporting the Recombinant CC10 Technology Platform

Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that it has received Notice of Allowance from the United States Patent […]

By |April 13th, 2016|Recent News|

Therabron Therapeutics Appoints Eric Richman as an Independent Board Member

Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced the appointment of Eric I. Richman as an independent director to the […]

By |April 4th, 2016|Recent News|